Unresectable Paraganglioma
specificParaganglioma that is not amenable to surgical resection.
14
Centers
13
Active Trials
—
Cancer Funding
Top Centers for Unresectable Paraganglioma(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 55.2 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 55.2 |
| 3 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 55.2 |
| 4 | NCI Comprehensive Active Research Program | 55.2 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 55.2 |
| 6 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 55.2 |
| 7 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 55.2 |
| 8 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 55.2 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 55.2 |
| 10 | Boston University Cancer CenterBoston, MA Active Research Program | 55.2 |
| 11 | Cancer Center at IllinoisUrbana, IL Active Research Program | 55.2 |
| 12 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 55.2 |
| 13 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 55.2 |
| 14 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 32.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →